Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Post by Mugen1996on Feb 14, 2011 9:10pm

465 Views

Post# 18133005

Stewardship Partners

As per the latest Institution update, SP has increased their holding in TH. Since the adoption of the "poison pill" last year, I tought the maximum was set to 10% per institution. SP is currently sitting at 10.18%

Name	Shares Held	% Total Shares Held	Shares Change	% Chg from Prior Port	% Total Assets	Date of Portfolio

Stewardship Partners Investment Counsel	6,166,515	10.18	83,790	1.38	30.86	12/31/2010